ニュージーランド - 英語 - Medsafe (Medicines Safety Authority)

baxter healthcare ltd - lidocaine hydrochloride monohydrate 10.66 mg/ml equivalent to lidocaine hydrochloride 10.0 mg/ml - solution for injection - 1% w/v - active: lidocaine hydrochloride monohydrate 10.66 mg/ml equivalent to lidocaine hydrochloride 10.0 mg/ml excipient: hydrochloric acid nitrogen sodium chloride sodium hydroxide water for injection - lidocaine solutions are indicated for the production of local or regional anaesthesia by the following techniques: local infiltration; minor or major nerve blocks; epidural block; arthroscopy; intravenous regional anaesthesia.

アイルランド - 英語 - HPRA (Health Products Regulatory Authority)

international medication systems (uk) ltd - lidocaine hydrochloride - solution for injection - 1 percent weight/volume - antiarrhythmics, class ib; lidocaine; amides; lidocaine

アイルランド - 英語 - HPRA (Health Products Regulatory Authority)

international medication systems (uk) ltd - lidocaine hydrochloride - solution for injection - 2 percent weight/volume - antiarrhythmics, class ib; lidocaine; amides; lidocaine

マルタ - 英語 - Malta Medicines Authority

mercury pharma international limited 4045 kingswood road, city west business park, co, dublin, ireland - lidocaine hydrochloride - solution for injection - lidocaine hydrochloride 1 mg/ml - anesthetics

マルタ - 英語 - Malta Medicines Authority

mercury pharma international limited 4045 kingswood road, city west business park, co, dublin, ireland - lidocaine hydrochloride - solution for injection - lidocaine hydrochloride 2 mg/ml - anesthetics

オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

dentsply sirona pty ltd - articaine hydrochloride, quantity: 40 mg/ml; adrenaline (epinephrine) acid tartrate, quantity: 18.2 microgram/ml (equivalent: adrenaline (epinephrine), qty 10 microgram/ml) - injection, solution - excipient ingredients: sodium chloride; sodium metabisulfite; sodium hydroxide; hydrochloric acid; water for injections - 4 percent articadent dental with adrenaline 1:100,000 is indicated for local or regional anaesthesia for both simple and complex dental procedures in adults, adolescents and children 4 years of age and older. 4 percent articadent dental with adrenaline 1:100,000 is indicated only for dental procedures.

アイルランド - 英語 - HPRA (Health Products Regulatory Authority)

dlrc pharma services limited - lidocaine hydrochloride - solution for injection - 1 percent weight/volume - antiarrhythmics, class ib; lidocaine; amides; lidocaine

アイルランド - 英語 - HPRA (Health Products Regulatory Authority)

dlrc pharma services limited - lidocaine hydrochloride - solution for injection - 2 percent weight/volume - antiarrhythmics, class ib; lidocaine; amides; lidocaine

アメリカ合衆国 - 英語 - NLM (National Library of Medicine)

baxter healthcare corporation - lidocaine hydrochloride (unii: v13007z41a) (lidocaine - unii:98pi200987) - lidocaine hydrochloride 4 mg in 1 ml - lidocaine hydrochloride administered intravenously is specifically indicated in the acute management of (1) ventricular arrhythmias occurring during cardiac manipulations, such as cardiac surgery and (2) life-threatening arrhythmias which are ventricular in origin, such as occur during acute myocardial infarction. hypersensitivity reactions, including anaphylactic reactions, have been reported with lidocaine. lidocaine hydrochloride is contraindicated in patients with a history of hypersensitivity to local anesthetics of the amide type. lidocaine is contraindicated in patients with stokes-adams syndrome, wolff-parkinson-white syndrome, or with severe degrees of sinoatrial, atrioventricular, or intraventricular block.

オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

bridgewest perth pharma pty ltd - lidocaine hydrochloride monohydrate, quantity: 10 mg/ml - injection, solution - excipient ingredients: sodium chloride; water for injections; sodium hydroxide; hydrochloric acid - lignocaine is indicated for the production of local or regional anaesthesia by nerve block, infiltration injection, caudal or other epidural blocks. treatment or prophylaxis of life-threatening ventricular arrhythmias, including those associated with myocardial infarction, general anaesthesia in patients predisposed to ventricular arrhythmias, digitalis intoxication or following resuscitation from cardiac arrest.